{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:48:24Z","timestamp":1788187704697,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:00:00Z","timestamp":1640044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:00:00Z","timestamp":1640044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s40123-021-00447-x","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T02:02:40Z","timestamp":1640052160000},"page":"387-401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Evaluation of Adverse Effects of Topical Glaucoma Medications on Trabeculectomy Outcomes Using the Glaucoma Medications Intensity Index"],"prefix":"10.1007","volume":"11","author":[{"given":"Jasper Ka Wai","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsz Kin","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy Shiu-ming","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0177-8178","authenticated-orcid":false,"given":"Jonathan Cheuk-hung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,21]]},"reference":[{"issue":"10","key":"447_CR1","doi-asserted-by":"publisher","first-page":"e0162229","DOI":"10.1371\/journal.pone.0162229","volume":"11","author":"RR Bourne","year":"2016","unstructured":"Bourne RR, Taylor HR, Flaxman SR, et al. Number of people blind or visually impaired by glaucoma worldwide and in world regions 1990\u20132010: a meta-analysis. PLoS ONE. 2016;11(10):e0162229.","journal-title":"PLoS ONE"},{"issue":"11","key":"447_CR2","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081\u201390.","journal-title":"Ophthalmology"},{"issue":"10","key":"447_CR3","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268\u201379.","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"447_CR4","first-page":"505","volume":"19","author":"HA Quigley","year":"1980","unstructured":"Quigley HA, Flower RW, Addicks EM, McLeod DS. The mechanism of optic nerve damage in experimental acute intraocular pressure elevation. Invest Ophthalmol Vis Sci. 1980;19(5):505\u201317.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"447_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.7326\/0003-4819-158-4-201302190-00008","volume":"158","author":"MV Boland","year":"2013","unstructured":"Boland MV, Ervin AM, Friedman DS, et al. Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the U.S. Preventive services task force. Ann Intern Med. 2013;158(4):271\u20139.","journal-title":"Ann Intern Med"},{"issue":"4","key":"447_CR6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","volume":"126","author":"Collaborative Normal-Tension Glaucoma Study Group","year":"1998","unstructured":"Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126(4):487\u201397.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"447_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass MA, Heuer DK, Higginbotham EJ,  et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701\u201313.","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"447_CR8","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ajo.2011.10.024","volume":"153","author":"SJ Gedde","year":"2012","unstructured":"Gedde SJ, Herndon LW, Brandt JD, et al. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol. 2012;153(5):804\u201314.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"447_CR9","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ajo.2011.10.026","volume":"153","author":"SJ Gedde","year":"2012","unstructured":"Gedde SJ, Schiffman JC, Feuer WJ, et al. Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012;153(5):789-803.e2.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"447_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jcjo.2016.07.013","volume":"52","author":"R Conlon","year":"2017","unstructured":"Conlon R, Saheb H, Ahmed II. Glaucoma treatment trends: a review. Can J Ophthalmol. 2017;52(1):114\u201324.","journal-title":"Can J Ophthalmol"},{"issue":"3","key":"447_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0002-9394(14)76730-3","volume":"112","author":"JD Brandt","year":"1991","unstructured":"Brandt JD, Wittpenn JR, Katz LJ, Steinmann WN, Spaeth GL. Conjunctival impression cytology in patients with glaucoma using long-term topical medication. Am J Ophthalmol. 1991;112(3):297\u2013301.","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"447_CR12","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/archopht.1994.01090230060021","volume":"112","author":"DC Broadway","year":"1994","unstructured":"Broadway DC, Grierson I, O\u2019Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol. 1994;112(11):1446\u201354.","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"447_CR13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/01.ico.0000116526.57227.82","volume":"23","author":"RJ Noecker","year":"2004","unstructured":"Noecker RJ, Herrygers LA, Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea. 2004;23(5):490\u20136.","journal-title":"Cornea"},{"issue":"11","key":"447_CR14","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s12325-010-0070-1","volume":"27","author":"DA Ammar","year":"2010","unstructured":"Ammar DA, Noecker RJ, Kahook MY. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells. Adv Ther. 2010;27(11):837\u201345.","journal-title":"Adv Ther"},{"issue":"3","key":"447_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0161-6420(89)32888-0","volume":"96","author":"MB Sherwood","year":"1989","unstructured":"Sherwood MB, Grierson I, Milgar L, Hitchings RA. Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon\u2019s capsule in glaucomatous patients. Ophthalmology. 1989;96(3):327\u201335.","journal-title":"Ophthalmology"},{"issue":"11","key":"447_CR16","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1001\/archopht.1990.01070130045027","volume":"108","author":"MJ Lavin","year":"1990","unstructured":"Lavin MJ, Wormald RL, Migdal CS, Hitchings RA. The influence of prior therapy on the success of trabeculectomy. Arch Ophthalmol. 1990;108(11):1543\u20138.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"447_CR17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jcjo.2014.11.006","volume":"50","author":"CE Saade","year":"2015","unstructured":"Saade CE, Lari HB, Berezina TL, Fechtner RD, Khouri AS. Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study. Can J Ophthalmol. 2015;50(2):132\u20136.","journal-title":"Can J Ophthalmol"},{"key":"447_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1751-0473-3-17","volume":"3","author":"Z Bursac","year":"2008","unstructured":"Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3:17.","journal-title":"Source Code Biol Med"},{"issue":"11","key":"447_CR19","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1001\/archopht.1994.01090230051020","volume":"112","author":"DC Broadway","year":"1994","unstructured":"Broadway DC, Grierson I, O\u2019Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile. Arch Ophthalmol. 1994;112(11):1437\u201345.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"447_CR20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/BF00182000","volume":"232","author":"H Mietz","year":"1994","unstructured":"Mietz H, Niesen U, Krieglstein GK. The effect of preservatives and antiglaucomatous medication on the histopathology of the conjunctiva. Graefes Arch Clin Exp Ophthalmol. 1994;232(9):561\u20135.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"447_CR21","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0161-6420(99)90116-1","volume":"106","author":"C Baudouin","year":"1999","unstructured":"Baudouin C, Pisella PJ, Fillacier K, et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology. 1999;106(3):556\u201363.","journal-title":"Ophthalmology"},{"issue":"12","key":"447_CR22","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1016\/j.ophtha.2004.06.023","volume":"111","author":"C Baudouin","year":"2004","unstructured":"Baudouin C, Hamard P, Liang H, Creuzot-Garcher C, Bensoussan L, Brignole F. Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term. Ophthalmology. 2004;111(12):2186\u201392.","journal-title":"Ophthalmology"},{"issue":"6","key":"447_CR23","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.ophtha.2007.08.010","volume":"115","author":"DC Musch","year":"2008","unstructured":"Musch DC, Gillespie BW, Niziol LM, Cashwell LF, Lichter PR, Collaborative Initial Glaucoma Treatment Study G. Factors associated with intraocular pressure before and during 9 years of treatment in the collaborative initial glaucoma treatment study. Ophthalmology. 2008;115(6):927\u201333.","journal-title":"Ophthalmology"},{"issue":"Suppl 1","key":"447_CR24","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/S0039-6257(02)00291-6","volume":"47","author":"JB Soltau","year":"2002","unstructured":"Soltau JB, Zimmerman TJ. Changing paradigms in the medical treatment of glaucoma. Surv Ophthalmol. 2002;47(Suppl 1):S2-5.","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"447_CR25","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1097\/IJG.0000000000000230","volume":"25","author":"F Duman","year":"2016","unstructured":"Duman F, Waisbourd M, Faria B, Addis V, Hsieh M, Ekici F, et al. Trabeculectomy in patients with glaucoma over 80 years of age: relatively short-term outcomes. J Glaucoma. 2016;25(3):e123\u20137.","journal-title":"J Glaucoma"},{"issue":"3","key":"447_CR26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/bjo.83.3.280","volume":"83","author":"MC Briggs","year":"1999","unstructured":"Briggs MC, Jay JL. Age over 46 years does not affect the pressure lowering effect of trabeculectomy in primary open angle glaucoma. Br J Ophthalmol. 1999;83(3):280\u20134.","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"447_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0002-9394(02)01658-6","volume":"134","author":"The AGIS Investigators","year":"2002","unstructured":"The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty. Am J Ophthalmol. 2002;134(4):481\u201398.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"447_CR28","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/s41433-018-0071-x","volume":"32","author":"TKH Hoang","year":"2018","unstructured":"Hoang TKH, Kim YK, Jeoung JW, Park KH. Relationship between age and surgical success after trabeculectomy with adjunctive mitomycin C. Eye (Lond). 2018;32(8):1321\u20138.","journal-title":"Eye (Lond)"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-021-00447-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-021-00447-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-021-00447-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T13:21:57Z","timestamp":1642598517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-021-00447-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,21]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["447"],"URL":"https:\/\/doi.org\/10.1007\/s40123-021-00447-x","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,21]]},"assertion":[{"value":"1 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}